US Stem Cell (USRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,017 | -4,697 | -5,160 | -4,436 | -14,205 |
| Depreciation Amortization | 579 | 1,203 | 1,105 | 1,364 | 1,388 |
| Accounts receivable | 2 | -4 | 141 | -85 | -5 |
| Accounts payable and accrued liabilities | 324 | 301 | 133 | 810 | -183 |
| Other Working Capital | 1,827 | 960 | 1,070 | 190 | 178 |
| Other Operating Activity | 188 | 542 | 816 | 130 | 1,847 |
| Operating Cash Flow | $-1,095 | $-1,694 | $-1,894 | $-2,026 | $-10,979 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | N/A | N/A | -1 | -19 |
| Investing Cash Flow | $-1 | $N/A | $N/A | $-1 | $-19 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 475 | 558 | N/A | 298 | 1,000 |
| Debt Issued | N/A | N/A | 463 | 3,000 | N/A |
| Debt Repayment | N/A | N/A | N/A | -3,000 | N/A |
| Common Stock Issued | 585 | 1,426 | 2,400 | 1,892 | 6,434 |
| Other Financing Activity | 0 | -257 | -1,040 | -138 | -1,878 |
| Financing Cash Flow | $1,059 | $1,727 | $1,823 | $2,052 | $5,556 |
| Beginning Cash Position | 37 | 3 | 75 | 50 | 5,492 |
| End Cash Position | N/A | 37 | 3 | 75 | 50 |
| Net Cash Flow | $-37 | $34 | $-72 | $25 | $-5,442 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,095 | -1,694 | -1,894 | -2,026 | -10,979 |
| Capital Expenditure | -1 | N/A | N/A | -1 | -19 |
| Free Cash Flow | -1,096 | -1,694 | -1,894 | -2,027 | -10,998 |